Skip to main content
. 2020 Apr 27;16(11):2001–2013. doi: 10.7150/ijbs.43825

Figure 7.

Figure 7

Cilostazol depressed the activation of p38MAPK and JNK signal. Cilostazol pre-treatment significantly inhibited the phosphorylation of p38MAPK and JNK (A-C). (***, p < 0.001; **, p < 0.01; *, p < 0.05, n = 3).